Bransonpharma SRL
The score of Bransonpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +46 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bransonpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Bransonpharma's financial analysis
- Solvency16.0%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bransonpharma
Bransonpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.342.054
- VAT number
- BE0875342054
- Peppol
- Registered · 0208:0875342054 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jul 2005
- Registered office
- 1850 Grimbergen
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Bransonpharma (SRL) has been based in Grimbergen since 2005, active in: activities of holding companies. For 2025, it reports a net profit of 30,298 € and equity of 174,472 €; its revenue is not published. Its solvency stands at 16.0%, below the median of its sector (55.6%).
Companies similar to Bransonpharma
Companies in the same business, of comparable size and area, outside its group.
- Aqua Holding Activities of holding companies Visé · balance sheet €1.09m
- BCA Cars Activities of holding companies Bassenge · balance sheet €1.09m
- TWEN Activities of holding companies Antwerp · balance sheet €1.10m
- Moloco Invest Activities of holding companies Antwerp · balance sheet €1.09m
- Avanty Holding Activities of holding companies Lommel · balance sheet €1.10m
- RG Team Activities of holding companies Theux · balance sheet €1.10m
- Publieck Activities of holding companies Ardooie · balance sheet €1.09m
- Fluence Activities of holding companies Bernissart · balance sheet €1.08m
Frequently asked questions about Bransonpharma
What is the revenue of Bransonpharma?
Bransonpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bransonpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0875342054 for Bransonpharma, if the company is VAT-registered. Its company number (CBE) is 0875.342.054.
Where is the registered office of Bransonpharma?
According to the CBE register, the registered office of Bransonpharma is in 1850 Grimbergen.
What is the equity of Bransonpharma?
At the close of the 2025 financial year, the equity of Bransonpharma amounts to 174,472 €, a solvency of 16.0% of total assets.
Who manages Bransonpharma?
The register lists 1 active mandates at Bransonpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bransonpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →